PMVP

Conviction 14HealthcareScan · Mon, Aug 10, 2026

PMVP$1.24+3.78%

ResistanceSupportVol 14

Vol MA14 376.06K

May 11May 28Jun 16Jul 6Jul 23Aug 10

PMV Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.pmvpharma.com ↗

Price1.24

Change+3.78%

Gap+0.84%

Rel volume0.54×

Avg volume372.01K

Avg $ vol452.86K

SMA 201.23

SMA 501.20

SMA 2001.28

Price vs 50+3.14%

Price vs 200-3.59%

MA stackmixed

50/200 cross—

Supertrenddown · 1.35

RSI (14)53

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D55 / 46

ADX (14)19

+DI / −DI18 / 21

RSI divergence—

MACD divergence—

ATR %+6.11%

ADR %6.70%

52w high1.80

52w low1.02

From 52w high-31.39%

Above 52w low+21.08%

New 52w highNo

SqueezeOff

Bollinger width32.82%

%B0.51

Donchian pos47.56%

Donchian high1.45

Donchian low1.04

AVWAP (52w high)1.42

vs AVWAP high-12.79%

AVWAP (52w low)1.41

vs AVWAP low-12.24%

OBV trendUp

Chaikin MF (20)0.14

Today vs 20d0.54×

Avg vol (14d)376.06K

Avg vol (20d)372.01K

Avg $ vol (20d)452.86K

Market cap65.86M

RS 3m (vs SPY)-21.89%

RS 6m (vs SPY)+2.55%

RS line new highNo

Trend template1/8

Technical rank49.7

1 week+10.27%

1 month-0.40%

3 months-12.41%

6 months+18.75%

1 year-14.83%

YTD+0.41%

P/E-0.85

P/B0.75

P/S—

P/FCF-0.89

EPS-1.48

Div yield—

ROE-88.38%

ROA-80.51%

Debt/Eq—

Current11.14

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-32.42%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value26.73M

Revenue—

Net income-18.04M

Gross profit—

Free cash flow-73.61M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out53.33M

Employees54

ListedFri, Sep 25, 2020

Free float43.1M

Float %80.8%

Short interest2.42M

Days to cover6.3d

Short volume41.0%

Squeeze score37 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank49.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.42

Support1.09

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PMVP

All disclosures →

No recent disclosed trades by Congress in PMVP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PMVP · 6 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Gallagher Carol Giltner Director · Stock Option (right to buy) · 2026-06-04	Grant	42K	$0	2026-06-04	2026-06-05
Gallagher Carol Giltner Director · Stock Option (right to buy) · 2026-06-04	Gift	42K	$0	2026-06-04	2026-06-05
FLOWERS KIRSTEN Director · Stock Option (right to buy) · 2026-06-04	Grant	42K	$0	2026-06-04	2026-06-05
LEVINE ARNOLD J Director · Stock Option (right to buy) · 2026-06-04	Grant	42K	$0	2026-06-04	2026-06-05
Stelzer Laurie Director · Stock Option (right to buy) · 2026-06-04	Grant	42K	$0	2026-06-04	2026-06-05
Gallagher Carol Giltner Director · Stock Option (right to buy) · 2026-06-04	Gift	42K	$0	2026-06-04	2026-06-05
BAUM CHARLES M Director · Stock Option (right to buy) · 2026-06-04	Grant	42K	$0	2026-06-04	2026-06-05

SEC filings

EDGAR filings in PMVP · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.